ArticleOncoTargets and therapy2017
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.
Hung-Wei Pan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it